US Stock MarketDetailed Quotes

ICUI ICU Medical

Watchlist
  • 146.330
  • -3.420-2.28%
Close Feb 28 16:00 ET
  • 146.325
  • -0.0050.00%
Post 20:01 ET
3.59BMarket Cap-30.30P/E (TTM)

ICU Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.76%204.03M
-55.94%40.21M
2.32%36.02M
5,665.47%82.04M
11.08%45.77M
367.51%166.2M
5,434.25%91.27M
1,424.69%35.21M
97.60%-1.47M
3,170.12%41.2M
Net income from continuing operations
-296.86%-117.69M
-38.96%-23.83M
-555.69%-32.98M
-115.48%-21.41M
-302.27%-39.47M
60.08%-29.66M
-10.37%-17.15M
154.80%7.24M
-32.91%-9.93M
74.23%-9.81M
Operating gains losses
19.58%2.52M
564.20%2.34M
-64.50%262K
-101.99%-13K
-117.71%-65K
4.93%2.11M
192.39%352K
-65.25%738K
298.18%652K
-38.42%367K
Depreciation and amortization
-4.05%219.51M
-7.26%53.01M
-4.82%55.6M
-3.65%55.4M
-0.36%55.5M
-2.71%228.77M
0.61%57.16M
-0.39%58.42M
-13.61%57.5M
4.82%55.7M
Other non cash items
28.86%48.44M
-1.26%10.08M
408.39%10.66M
-31.78%13.51M
28.49%14.2M
2.26%37.59M
-41.32%10.2M
-150.30%-3.46M
308.28%19.8M
-49.78%11.05M
Change In working capital
98.11%-2.57M
-225.69%-17.67M
64.24%-13.49M
129.82%24.49M
113.74%4.1M
55.35%-135.6M
120.17%14.06M
40.27%-37.71M
31.35%-82.11M
41.82%-29.84M
-Change in receivables
-196.32%-46.84M
-736.64%-35.33M
-391.43%-18.23M
79.42%-7.25M
-82.97%13.97M
353.96%48.64M
154.43%5.55M
52.83%-3.71M
-49.42%-35.23M
264.75%82.03M
-Change in inventory
376.84%16.83M
-87.76%7.41M
-224.54%-11.68M
125.99%6.93M
128.69%14.16M
96.98%-6.08M
223.00%60.58M
118.10%9.38M
58.23%-26.67M
-36.49%-49.37M
-Change in prepaid assets
-175.64%-8.83M
525.73%2.36M
-82.56%1.45M
-741.54%-6.9M
-400.73%-5.74M
-49.04%11.67M
-86.67%377K
-45.90%8.31M
-48.83%1.08M
-26.85%1.91M
-Change in payables and accrued expense
140.11%33.2M
-16.28%-8.37M
141.57%11.89M
2,367.81%40.87M
76.99%-11.19M
-350.82%-82.78M
32.75%-7.2M
-872.70%-28.61M
114.24%1.66M
-18,379.70%-48.62M
-Change in other current assets
6.24%-23.15M
3.79%-5.61M
-4.12%-6.42M
4.58%-5.96M
19.98%-5.16M
-15.99%-24.7M
-547.47%-5.84M
-16.90%-6.16M
-111.72%-6.25M
55.13%-6.45M
-Change in other working capital
131.85%26.23M
155.48%21.87M
156.14%9.5M
80.88%-3.19M
79.14%-1.95M
-23.41%-82.36M
-969.08%-39.42M
1.92%-16.92M
15.24%-16.69M
64.26%-9.33M
Cash from discontinued investing activities
Operating cash flow
22.76%204.03M
-55.96%40.19M
2.66%36.1M
5,659.91%81.95M
11.02%45.79M
367.51%166.2M
5,434.25%91.27M
1,422.78%35.16M
97.60%-1.47M
3,173.40%41.25M
Investing cash flow
Cash flow from continuing investing activities
-1.15%-88.96M
13.39%-26.55M
6.72%-22.86M
-23.21%-21.69M
-17.64%-17.86M
95.39%-87.95M
-27.72%-30.65M
-95.63%-24.51M
-239.10%-17.61M
99.19%-15.18M
Net PPE purchase and sale
5.39%-79.37M
19.56%-24.08M
7.25%-19.91M
-6.47%-19.47M
-12.04%-15.92M
7.11%-83.89M
-38.62%-29.94M
-3.83%-21.47M
25.17%-18.28M
39.82%-14.21M
Net intangibles purchase and sale
-10.80%-10.83M
-23.64%-2.52M
4.46%-2.95M
-13.73%-2.41M
-16.67%-2.95M
-8.42%-9.78M
17.21%-2.04M
-45.80%-3.09M
-3.21%-2.12M
-6.07%-2.53M
Net business purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
-88.16%500K
--0
--0
--0
-66.67%500K
-87.22%4.22M
--1.3M
--0
-93.33%1.42M
-0.46%1.5M
Net other investing changes
-50.30%746K
155.00%51K
-94.00%3K
-86.56%185K
838.89%507K
51.77%1.5M
-64.29%20K
51.52%50K
--1.38M
-94.00%54K
Cash from discontinued investing activities
Investing cash flow
-1.15%-88.96M
13.39%-26.55M
6.72%-22.86M
-23.21%-21.69M
-17.64%-17.86M
95.39%-87.95M
-27.72%-30.65M
-95.63%-24.51M
-239.10%-17.61M
99.19%-15.18M
Financing cash flow
Cash flow from continuing financing activities
-55.09%-55.8M
-4.36%-8.19M
-62.29%-10.38M
-76.09%-10.38M
-69.51%-26.85M
-102.20%-35.98M
24.42%-7.85M
-352.81%-6.4M
-46.33%-5.9M
-100.96%-15.84M
Net issuance payments of debt
-70.13%-52.15M
-69.97%-13.12M
-35.47%-10.41M
-103.80%-15.62M
-71.37%-13M
-101.87%-30.65M
27.15%-7.72M
-236.78%-7.68M
-225.80%-7.67M
-100.46%-7.58M
Proceeds from stock option exercised by employees
171.98%10.94M
--5.06M
57.02%2.81M
41.80%2.92M
-12.28%150K
-54.22%4.02M
--0
-63.59%1.79M
11,355.56%2.06M
-94.25%171K
Net other financing activities
-56.06%-14.59M
3.10%-125K
-453.08%-2.78M
890.10%2.32M
-66.17%-14M
28.41%-9.35M
80.66%-129K
-388.35%-503K
82.71%-293K
20.48%-8.43M
Cash from discontinued financing activities
Financing cash flow
-55.09%-55.8M
-4.36%-8.19M
-62.29%-10.38M
-76.09%-10.38M
-69.51%-26.85M
-102.20%-35.98M
24.42%-7.85M
-352.81%-6.4M
-46.33%-5.9M
-100.96%-15.84M
Net cash flow
Beginning cash position
21.76%254.22M
58.48%312.51M
54.50%302.65M
13.79%251.42M
21.76%254.22M
-62.23%208.78M
-19.14%197.19M
-23.39%195.89M
-32.93%220.95M
-62.23%208.78M
Current changes in cash
40.21%59.27M
-89.66%5.46M
-32.89%2.86M
299.69%49.88M
-89.40%1.08M
112.64%42.28M
246.20%52.77M
155.36%4.26M
64.63%-24.98M
104.64%10.23M
Effect of exchange rate changes
-255.83%-4.93M
-320.68%-9.4M
337.36%7.01M
1,724.10%1.35M
-300.36%-3.88M
133.37%3.16M
326.43%4.26M
28.52%-2.95M
97.34%-83K
160.11%1.94M
End cash Position
21.38%308.57M
21.38%308.57M
58.48%312.51M
54.50%302.65M
13.79%251.42M
21.76%254.22M
21.76%254.22M
-19.14%197.19M
-23.39%195.89M
-32.93%220.95M
Free cash flow
56.94%113.83M
-77.07%13.6M
24.81%13.23M
374.61%60.08M
9.85%26.92M
144.92%72.53M
330.15%59.3M
151.75%10.6M
75.10%-21.88M
189.66%24.51M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.76%204.03M-55.94%40.21M2.32%36.02M5,665.47%82.04M11.08%45.77M367.51%166.2M5,434.25%91.27M1,424.69%35.21M97.60%-1.47M3,170.12%41.2M
Net income from continuing operations -296.86%-117.69M-38.96%-23.83M-555.69%-32.98M-115.48%-21.41M-302.27%-39.47M60.08%-29.66M-10.37%-17.15M154.80%7.24M-32.91%-9.93M74.23%-9.81M
Operating gains losses 19.58%2.52M564.20%2.34M-64.50%262K-101.99%-13K-117.71%-65K4.93%2.11M192.39%352K-65.25%738K298.18%652K-38.42%367K
Depreciation and amortization -4.05%219.51M-7.26%53.01M-4.82%55.6M-3.65%55.4M-0.36%55.5M-2.71%228.77M0.61%57.16M-0.39%58.42M-13.61%57.5M4.82%55.7M
Other non cash items 28.86%48.44M-1.26%10.08M408.39%10.66M-31.78%13.51M28.49%14.2M2.26%37.59M-41.32%10.2M-150.30%-3.46M308.28%19.8M-49.78%11.05M
Change In working capital 98.11%-2.57M-225.69%-17.67M64.24%-13.49M129.82%24.49M113.74%4.1M55.35%-135.6M120.17%14.06M40.27%-37.71M31.35%-82.11M41.82%-29.84M
-Change in receivables -196.32%-46.84M-736.64%-35.33M-391.43%-18.23M79.42%-7.25M-82.97%13.97M353.96%48.64M154.43%5.55M52.83%-3.71M-49.42%-35.23M264.75%82.03M
-Change in inventory 376.84%16.83M-87.76%7.41M-224.54%-11.68M125.99%6.93M128.69%14.16M96.98%-6.08M223.00%60.58M118.10%9.38M58.23%-26.67M-36.49%-49.37M
-Change in prepaid assets -175.64%-8.83M525.73%2.36M-82.56%1.45M-741.54%-6.9M-400.73%-5.74M-49.04%11.67M-86.67%377K-45.90%8.31M-48.83%1.08M-26.85%1.91M
-Change in payables and accrued expense 140.11%33.2M-16.28%-8.37M141.57%11.89M2,367.81%40.87M76.99%-11.19M-350.82%-82.78M32.75%-7.2M-872.70%-28.61M114.24%1.66M-18,379.70%-48.62M
-Change in other current assets 6.24%-23.15M3.79%-5.61M-4.12%-6.42M4.58%-5.96M19.98%-5.16M-15.99%-24.7M-547.47%-5.84M-16.90%-6.16M-111.72%-6.25M55.13%-6.45M
-Change in other working capital 131.85%26.23M155.48%21.87M156.14%9.5M80.88%-3.19M79.14%-1.95M-23.41%-82.36M-969.08%-39.42M1.92%-16.92M15.24%-16.69M64.26%-9.33M
Cash from discontinued investing activities
Operating cash flow 22.76%204.03M-55.96%40.19M2.66%36.1M5,659.91%81.95M11.02%45.79M367.51%166.2M5,434.25%91.27M1,422.78%35.16M97.60%-1.47M3,173.40%41.25M
Investing cash flow
Cash flow from continuing investing activities -1.15%-88.96M13.39%-26.55M6.72%-22.86M-23.21%-21.69M-17.64%-17.86M95.39%-87.95M-27.72%-30.65M-95.63%-24.51M-239.10%-17.61M99.19%-15.18M
Net PPE purchase and sale 5.39%-79.37M19.56%-24.08M7.25%-19.91M-6.47%-19.47M-12.04%-15.92M7.11%-83.89M-38.62%-29.94M-3.83%-21.47M25.17%-18.28M39.82%-14.21M
Net intangibles purchase and sale -10.80%-10.83M-23.64%-2.52M4.46%-2.95M-13.73%-2.41M-16.67%-2.95M-8.42%-9.78M17.21%-2.04M-45.80%-3.09M-3.21%-2.12M-6.07%-2.53M
Net business purchase and sale --0------------------0----------------
Net investment purchase and sale -88.16%500K--0--0--0-66.67%500K-87.22%4.22M--1.3M--0-93.33%1.42M-0.46%1.5M
Net other investing changes -50.30%746K155.00%51K-94.00%3K-86.56%185K838.89%507K51.77%1.5M-64.29%20K51.52%50K--1.38M-94.00%54K
Cash from discontinued investing activities
Investing cash flow -1.15%-88.96M13.39%-26.55M6.72%-22.86M-23.21%-21.69M-17.64%-17.86M95.39%-87.95M-27.72%-30.65M-95.63%-24.51M-239.10%-17.61M99.19%-15.18M
Financing cash flow
Cash flow from continuing financing activities -55.09%-55.8M-4.36%-8.19M-62.29%-10.38M-76.09%-10.38M-69.51%-26.85M-102.20%-35.98M24.42%-7.85M-352.81%-6.4M-46.33%-5.9M-100.96%-15.84M
Net issuance payments of debt -70.13%-52.15M-69.97%-13.12M-35.47%-10.41M-103.80%-15.62M-71.37%-13M-101.87%-30.65M27.15%-7.72M-236.78%-7.68M-225.80%-7.67M-100.46%-7.58M
Proceeds from stock option exercised by employees 171.98%10.94M--5.06M57.02%2.81M41.80%2.92M-12.28%150K-54.22%4.02M--0-63.59%1.79M11,355.56%2.06M-94.25%171K
Net other financing activities -56.06%-14.59M3.10%-125K-453.08%-2.78M890.10%2.32M-66.17%-14M28.41%-9.35M80.66%-129K-388.35%-503K82.71%-293K20.48%-8.43M
Cash from discontinued financing activities
Financing cash flow -55.09%-55.8M-4.36%-8.19M-62.29%-10.38M-76.09%-10.38M-69.51%-26.85M-102.20%-35.98M24.42%-7.85M-352.81%-6.4M-46.33%-5.9M-100.96%-15.84M
Net cash flow
Beginning cash position 21.76%254.22M58.48%312.51M54.50%302.65M13.79%251.42M21.76%254.22M-62.23%208.78M-19.14%197.19M-23.39%195.89M-32.93%220.95M-62.23%208.78M
Current changes in cash 40.21%59.27M-89.66%5.46M-32.89%2.86M299.69%49.88M-89.40%1.08M112.64%42.28M246.20%52.77M155.36%4.26M64.63%-24.98M104.64%10.23M
Effect of exchange rate changes -255.83%-4.93M-320.68%-9.4M337.36%7.01M1,724.10%1.35M-300.36%-3.88M133.37%3.16M326.43%4.26M28.52%-2.95M97.34%-83K160.11%1.94M
End cash Position 21.38%308.57M21.38%308.57M58.48%312.51M54.50%302.65M13.79%251.42M21.76%254.22M21.76%254.22M-19.14%197.19M-23.39%195.89M-32.93%220.95M
Free cash flow 56.94%113.83M-77.07%13.6M24.81%13.23M374.61%60.08M9.85%26.92M144.92%72.53M330.15%59.3M151.75%10.6M75.10%-21.88M189.66%24.51M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Cars.com
CARS
+9.73%
Lantheus
LNTH
+2.55%
Halozyme Therapeutics
HALO
+2.51%
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+2.27%
Collegium Pharmaceutical
COLL
+2.22%

Unlock the Full List